alexander perl, md, discusses treatment options for patients with flt3-itd positive aml
Published 7 years ago • 48 plays • Length 1:40
Download video MP4
Download video MP3
Similar videos
-
1:59
alexander perl, md, discusses treatment options for aml patients
-
2:10
alexander perl, md, on prognosis, diagnosis and treatment strategies for aml
-
0:58
alexander perl, md, discusses the importance of sustained inhibition when selecting a flt3 inhibitor
-
1:14
alexander perl, md, discusses the potential impact of potency when selecting a flt3 inhibitor
-
0:53
alexander perl, md, discusses the quantum first study and potential implications
-
0:59
alexander perl, md, discusses how molecular testing can facilitate decision making in aml patients
-
1:07:54
management of flt3 positive aml with dr. alexander perl
-
0:54
alexander perl, md, discusses abstract 7008 results and crenolanib potential activity
-
1:25
dr. perl on the outlook of flt3 inhibitors for aml
-
9:39
alexander perl, md: the new flt3 inhibitor gilteritinib is “well-tolerated” in aml
-
1:23
alexander perl, md discusses cpx-351 (vyxeos) mechanism of action and why it is a promising agent
-
1:17
alexander perl, md, on the role of immunotherapy in treating hematological malignancies
-
1:18
alexander perl, md, on flt3 inhibitors in development and importance of hitting the flt3 target
-
2:20
best treatment strategy for flt3 itd aml
-
1:54
dr. wang discusses treatment options for flt3-mutated aml
-
1:01
alexander perl, md, on how the beat aml master trial will change the way aml patients are treated
-
2:08
comparing midostaurin to next-generation flt3 inhibitors in the frontline treatment of flt3-itd aml
-
4:04
dr. alexander perl, m.d., associate professor of medicine at the university of pennsylvania
-
1:23
dr. perl discusses upcoming car t-cell therapies for all
Clip.africa.com - Privacy-policy